The quality of life of sufferers of chronic and serious diseases is a phenomenon which has come to the attention of contemporary medicine, nursing and other supporting professionals working with cancer patients. This research set out to determine whether there is a difference in the self-perception of the quality of life of hospitalized cancer patients and cancer outpatients. This study deals with the comparison of quality of life in 128 outpatient and hospitalized cancer patients in the curative stage of cancer. The QLACS (Quality of Life in Adult Cancer Survivors) “How do I live with the disease?” questionnaire was used in the survey. To ascertain the total value of the quality of life we used scoring with a potential spread of responses from 1 to 7 in the QLACS questionnaire. Using this scale, various items in the questionnaire measured the level of each frequency of problems (1 = never, 7 = always). The resulting value of quality of life of the patient was higher when the final score was lower. A significance level of 0.005 in the resulting value of quality of life (sig. = 0.000) in the study group of patients confirmed the hypothesis, which assumed that the quality of life of hospitalized cancer patients is significantly lower than the quality of life of cancer outpatients. The quality of life of hospitalized cancer patients is significantly lower than the quality of life of cancer outpatients (sig. = 0.000) since admission to hospital with all the accompanying negative factors for the patient – the separation from family and loved ones, unfamiliar environment, undergoing often difficult and invasive diagnostic or therapeutic procedures, which amongst others, are very stressful for the patient, with a potentially negative impact on the patient’s quality of life.
- MeSH
- interpretace statistických dat MeSH
- kvalita života * psychologie MeSH
- lidé MeSH
- nádory epidemiologie psychologie MeSH
- pacienti ambulantní psychologie statistika a číselné údaje MeSH
- pacienti hospitalizovaní psychologie statistika a číselné údaje MeSH
- průzkumy a dotazníky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
Kryptorchizmus je najčastejšia vrodená chyba mužských pohlavných orgánov znamenajúca neprítomnosť semenníkov v skróte. Pri narodení má približne 5 % donosených novorodencov nezostúpený semenník, vo veku 12 mesiacov je to už len 1 %. Keďže v 6. mesiaci dochádza k znižovaniu počtu zárodočných buniek a spontánny zostup po tomto období je vzácny, liečba kryptorchizmu už môže začať v tomto období a mala by byť ukončená do veku 18 mesiacov. Pri hmatnom semenníku je indikovaná operačná liečba – orchidopexia z inguinálneho prístupu, pri nehmatnom semenníku je indikovaná diagnostická laparoskopia – pri náleze nízko uloženého intraabdominálneho semenníka je možná jednodobá orchidopexia bez prerušenia testikulárnych ciev, pri vysoko uloženom intraabdominálnom semenníku sa pokračuje jednodobou alebo dvojdobou orchidopexiou s prerušením testikulárnych ciev. V súčasnosti získava v liečbe kryptorchizmu význam adjuvantná hormonálna liečba k operačnej liečbe, ktorá môže zlepšiť fertilitu. Hormonálna liečba je však stále kontroverzná a aj napriek pozitívnemu vplyvu na fertilitu má mnoho odporcov a zatiaľ nie je štandardnou liečbou kryptorchizmu.
Cryptorchidism is the most common congenital anomaly of the male genitalia meaning the absence of testicles in the scrotum. Approximately 5% of full-term newborn males have undescended testicle, at the age of 12 months it is only 1%. As in the 6th month there starts a decrease of germ cell count and the spontaneous descent after this age is rare, the therapy of cryptorchidism should start already at this age and should be completed until the age of 18 months. If the testicle is palpable the orchidopexy from the inguinal approach is indicated. If the testicle is unpalpable the diagnostic laparoscopy is indicated. If a low intra-abdominal testicle is found, one-stage orchidopexy without transection of testicular vessels is possible, if a high intra-abdominal testicle is found one or two stage orchidopexy with the transection of testicular vessels is performed. At the present time the postoperative hormonal treatment becomes significant in the treatment of the cryptorchidism and may have a beneficial effect on fertility. The hormonal treatment is still controversial and has many opponents despite the positive influence on the fertility, yet it is still not a standard treatment for cryptorchidism.
- MeSH
- choriogonadotropin škodlivé účinky terapeutické užití MeSH
- fyzikální vyšetření metody MeSH
- hormon uvolňující gonadotropiny škodlivé účinky terapeutické užití MeSH
- kojenec MeSH
- kombinovaná terapie MeSH
- kryptorchismus * diagnóza epidemiologie etiologie terapie MeSH
- laparoskopie metody MeSH
- látky působící na reprodukci škodlivé účinky terapeutické užití MeSH
- lidé MeSH
- mužská infertilita prevence a kontrola MeSH
- orchidopexe metody MeSH
- předškolní dítě MeSH
- testikulární nádory prevence a kontrola MeSH
- testis embryologie chirurgie růst a vývoj účinky léků MeSH
- urologické chirurgické výkony u mužů metody MeSH
- zárodečné buňky růst a vývoj MeSH
- Check Tag
- kojenec MeSH
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
